Toshiba Corp. announced the development of a device that can detect 13 types of cancer with a single drop of blood
The device is able to differentiate between cancer patients and healthy people, with a 99% accuracy.
The results of the blood test can be produced in less than 2 hours and it will costs ¥20,000 or less.
Compared to other companies’ methods, we have an edge in the degree of accuracy in cancer detection, the time required for detection and the cost – Koji Hashimoto, Chief Research Scientist at Toshiba’s Frontier Research Laboratory
The test will be used to detect gastric, esophageal, lung, liver, biliary tract, pancreatic, bowel, ovarian, prostate, bladder and breast cancers as well as sarcoma and glioma.
In its five-year business strategy from April 2019, Toshiba has positioned medical businesses, including genome analysis and cell diagnosis, among key growth pillars along with automation, batteries and digital solutions using artificial intelligence.
